Rejected at 3:20 a.m. Nov, 01, 2023 ] by Ahmed7
Bulk Suggestion Bulk ID: Sameem/05.30.23-03:07PM
Author: Sameem
Related Note: 1488847688890 1
Rationale for change

Pixorize media update
MSK pharma tag

Rejection reason

Bulk rejection

Text
Aspirin is a(n) {{c1::irreversible::reversible/irreversible}} inhibitor of COX-1 and COX-2
Extra
Thus, the effects of aspirin last until new platelets are produced
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy




Watch Antiplatelet Agents
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Physeo

Bootcamp
Watch associated Bootcamp video - Antiplatelet Medications

Watch associated Bootcamp video - Pharmacology : Arachidonic Acid Pathways

Watch associated Bootcamp video - Pharmacology : NASIDs

Watch associated Bootcamp video - Pharmacology : Aspirin & Celecoxib

Watch associated Bootcamp video - Inflammatory Response: Acute Inflammatory Response
OME

Additional Resources
One by one
Empty field
Changed Tags
#AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::03_Antiplatelet_Agents #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::03_Antiplatelet_agents
#AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_Connective_Tissue::04_Pharm::03_Aspirin #AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::04_Aspirin_And_Celecoxib #AK_Step1_v12::#B&B::11_Hematology::01_Hemostasis::07_Anticoagulants #PANCE::CARDIO::coronary_artery_disease #AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::03_NSAIDs #AK_Step1_v12::#B&B::12_Immunology::03_Pharm::01_Glucocorticoids_&_NSAIDs #AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::01_Arachidonic_Acid_Pathways #AK_Step1_v12::#Pixorize::03_Pharmacology::13_Musculoskeletal_Pharm::01_Aspirin #AK_Step1_v12::#FirstAid::10_Hematology_Oncology::05_Pharm::08_Aspirin #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#UWorld::Step::714 #AK_Step1_v12::#Bootcamp::Immunology::03_Inflammatory_Response::01_Acute_Inflammatory_Response #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#UWorld::COMLEX::23826 #AK_Step1_v12::#Physeo::09_Pharm::09_Musculoskeletal::02_Aspirin #AK_Step1_v12::#AMBOSS::QJauFl #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#AMBOSS::3iaSr4 #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::06_Platelets::05_Antiplatelet_Medications #AK_Step1_v12::#B&B::11_Hematology::01_Hemostasis::06_Antiplatelet_Drugs #PANCE::EOR::IM #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#AMBOSS::PiaW74 #AK_Step1_v12::#Physeo::^physeo_image_update